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Abstract
Background In Belgium and the Netherlands, up to 40% of
the children on dialysis are children with immigrant parents
of non-Western European origin (non-Western). Concerns
exist regarding whether these non-Western patients receive
the same quality of care as children with parents of Western
European origin (Western). We compared initial dialysis,
post-initial treatment, and outcomes between non-Western
and Western patients on dialysis.
Methods All children <19 years old on chronic dialysis in
the Netherlands and Belgium between September 2007 and
May 2011 were included in the study. Non-Western patients
were defined as children of whom one or both parents were
born in non-Western countries.
Results Seventy-nine of the 179 included patients (44%)
were non-Western children. Compared to Western patients,
non-Western patients more often were treated with hemodi-
alysis (HD) instead of peritoneal dialysis (PD) as first
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dialysis mode (52 vs. 37%, p00.046). Before renal trans-
plantation, non-Western patients were on dialysis for a me-
dian (range) of 30 (5–99) months, vs. 15 (0–66) months in
Western patients (p00.007). Renal osteodystrophy was di-
agnosed in 34% of non-Western vs. 18% of Western patients
(p00.028). The incidence rate ratio [95% confidence inter-
val] for acute peritonitis was 2.44 [1.43-4.17] (p00.032) for
non-Western compared to Western patients.
Conclusions There are important disparities between chil-
dren on chronic dialysis with parents from Western Europe-
an origin and those from non-Western European origin in
the choice of modality, duration, and outcomes of dialysis
therapy.
Keywords End-stage renal disease . Dialysis . Children with
immigrant parents . Non-Western European . Renal
osteodystrophy
Introduction
In the Netherlands and Belgium, a considerable propor-
tion of children treated with chronic dialysis have
immigrant parents from non-Western European origin
(non-Western). Over the last decade, the proportion of
non-Western immigrants in the Netherlands has grown
from 9 to 11% [1]. Data on clinical management and
outcomes of patients of ethnic minorities are scarce.
Yet, there is a growing awareness that there are consid-
erable healthcare disparities between immigrants and
native American patients [2, 3]. Stronks et al. showed
that in the Netherlands, the use of general practitioner
care and the use of prescribed drugs has increased
among non-Western adult patients as compared to adult
patients from Western European (Western) origin [4].
Cultural misunderstandings between doctor and patient
as well as language barriers may contribute to a different
approach and subsequent disparities in quality of care. For
example, a Dutch study on asthma in children showed
ethnicity and limited Dutch proficiency to be important risk
factors for uncontrolled asthma in children [5]. Disparities
for patients of non-Western background may be even more
important for highly complex modes of healthcare such as
chronic renal replacement therapy in children, which makes
great demands on the understanding and discipline of
patients and caretakers.
Little is known about the management and outcomes of
children of non-Western immigrant parents requiring chron-
ic dialysis. We therefore compared the choice of initial
dialysis modality, post-initial treatment, and outcomes be-
tween first- and second-generation children of non-Western
origin and those from Western origin on chronic dialysis
treatment.
Methods
Patients
All children aged<19 years who were treated with hemodial-
ysis (HD) or peritoneal dialysis (PD) in the Netherlands and
Belgium between September 1, 2007 and May 1, 2011 were
included. Data were collected as part of the RICH-Q project
(Renal Insufficiency therapy in Children - Quality assessment
and improvement) [6]. Follow-up data were available until
May 1, 2011, or until transplantation, transition to adult care,
or death. We obtained ethical approval from the ethical insti-
tutional review boards of all participating hospitals and written
informed consent from the parents of all participants, and the
participants themselves, if possible.
Survey on preferred first dialysis therapy
At the start of RICH-Q in 2007 we asked one pediatric
nephrologist per participating center to complete a question-
naire on treatment policies. The questionnaire was devel-
oped with input from all participating pediatric
nephrologists to ensure content validity. The questionnaire
included the following question: What is your preferred first
mode of renal replacement therapy, if pre-emptive transplan-
tation is not possible, in children>3 years old?
Data collection procedures
Data were collected from the medical records of the patients by
trained local research nurses or by the participating pediatric
nephrologists. The following data were used: age, gender,
primary cause of end-stage renal disease (ESRD), date of first
chronic renal replacement therapy (cRRT), first cRRT modal-
ity, waiting time on dialysis, country of birth for the child and
parents, race/ethnicity as reported by the parents , i.e., Cauca-
sian, Black, Asian, or other, and the educational attainment of
the parents. Primary causes of ESRDwere classified into seven
categories: glomerulopathy, hemolytic uremic syndrome, uri-
nary tract malformation, dysplasia, primary interstitial nephri-
tis, tubular necrosis, or other. The following outcomes were
recorded: blood values of hemoglobin, phosphate, calcium,
immunoreactive parathyroid hormone (iPTH), alkaline phos-
phatase, homocysteine, presence of hypertension, medication
prescriptions, and presence of metabolic bone disease at inclu-
sion of the patients from 2007 until 2011. Complications of the
therapy, such as peritonitis incidence, HD infections, and hos-
pitalizations were monitored during the 4-year study period.
Definitions
Non-Western patients were defined as children of whom one
or both parents were born in non-Western European
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countries [1]. Western patients were defined as children
from parents born in Western Europe. The total number of
months on dialysis was defined as the period between the
first day of dialysis and May 1, 2011 or the date of trans-
plantation, the date of transition to adult care, or the date of
death. For the calculation of the estimated glomerular filtra-
tion rate (eGFR), we used the updated version of the
Schwartz formula: eGFR (ml/min/1.73 m2)00.413* (height
in cm) / serum creatinine in mg/dl) [7]. The mean was
calculated of three systolic and three diastolic blood pres-
sure measurements at the time of inclusion. Hypertension
was defined as either a systolic or diastolic blood pressure>
p95 of the Task Force Report normal values corrected for
age and gender [8]. Renal osteodystrophy (ROD) was diag-
nosed by an experienced radiologist based on a hand X-ray
at the time of inclusion. We made a distinction between
“incident patients”, who were included within 3 months
after the start of dialysis, and “prevalent patients” defined
as patients who had been treated with dialysis for at least
3 months before inclusion. “Poor condition as reason to start
dialysis” was defined by the pediatric nephrologists. Paren-
tal educational attainment was defined as the highest edu-
cational level as reported by the parents themselves.
Statistical analysis
Chi-square test or, in case of small expected cell counts,
Fisher’s exact test, was used to test comparisons of categor-
ical variables between non-Western and Western patients.
Student’s t test and Mann–Whitney U test were used for
continuous variables when appropriate.
Kaplan–Meier survival analysis was used to analyze wait-
ing time on dialysis until transplantation. To investigate the
association between non-Western status and number of peri-
tonitis episodes per PD year at risk and ROD, respectively,
linear and logistic regression analysis was performed. At first,
only the central determinant was entered into the model (mod-
el with one determinant); possible confounders were then
entered one at a time (multivariable models). If the regression
coefficient of the central determinant ‘non-Western status’
changed >10% after the addition of one determinant to the
regressionmodel, this added determinant was considered to be
a confounder and was kept in the final model. To evaluate the
change in the regression coefficient, the same population was
included in the bi-variable analysis as in the multivariable
analysis, i.e., excluding any subjects with missing values.
The following determinants were considered as possible
confounders: the duration of dialysis before inclusion, poor
condition as the reason to start dialysis, the cause of ESRD,
and educational attainment of parents.
All analyses were performed using SPSS 18.0 for Win-
dows statistical software. For the incidence rate of infection
and hospitalization, the number of new episodes per patient
year at risk was calculated. The incidence rate ratio (IRR)
was calculated to compare non-Western and Western
patients. Hospitalization was analyzed separately in chil-
dren<4 years old, because the hospitalization rate is on
average higher in young children.
Results
Characteristics and initial treatment
We included 179 children, of whom 79 (44%) had parents
from non-Western origin (Table 1). In four patients (2%),
only one parent was from non-Western origin; we consid-
ered these patients as ‘non-Western’ according to the defi-
nition of Statistics Netherlands (CBS) [1].
We found no statistically significant differences be-
tween non-Western and Western patients with respect to
primary cause of ESRD, gender, age at start of dialysis
(HD or PD), eGFR at start of dialysis, poor condition as
the reason to start dialysis, PD modality, or percentage of
patients already treated with dialysis at the time of inclu-
sion. Compared with Western children, non-Western chil-
dren were significantly more often treated with HD as the
first mode of cRRT, 37 vs. 52%, respectively (p00.046).
The median duration of dialysis at the start of the RICH-Q
project was 9 months longer in non-Western patients; in
patients treated with HD, this difference was statistically
significant (p00.018). Parents of non-Western European
origin had a significantly lower level of educational at-
tainment (Table 1).
Preferred first dialysis therapy
Of the ten centers, six (60%) preferred PD as first dialysis
treatment if pre-emptive transplantation was not possible for
children>3 years old. In the four centers preferring HD, this
preferred mode of dialysis was more often followed in non-
Western children than in Western children (p00.006).
Post-initial dialysis treatment
Compared with Western patients, non-Western patients had
a significantly longer median duration of HD, the median
difference exceeding 10 months (p00.003) (Table 2). No
significant disparities were found between the two groups
for the median duration of PD, the number of switches in
therapy, medication use, or the time on hemodialysis per
week (Table 2). Relatively more non-Western than Western
patients on HD had a Cimino fistula instead of a central
venous catheter (53 vs. 33%), although this difference was
not statistically significant (p00.080).
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Table 1 Demographics, cause of end-stage renal disease (ESRD) and initial treatment of children with immigrant parents of non-western European
origin (non-Western) and children with parents of western-European origin (Western)
Non-Western, n079 (44) Western,
n0100 (56)
p value
Male 50 (63) 52 (52) 0.130a
Origin of parents Morocco: 15 Netherlands: 63 -
Turkey: 15 Belgium: 34
Surinam: 9 Germany: 1
Asia: 5 Luxembourg: 1
Dutch Antilles/Caribbean: 3 United Kingdom: 1
Russia: 2
Africa (other): 15
Middle East (other): 15
Country of birth Netherlands: 37 Netherlands: 63 -
Belgium: 13 Belgium: 34
United Kingdom: 2 Germany: 1
Morocco: 2 Luxembourg: 1
Turkey: 3 United Kingdom: 1
Surinam: 3
Asia: 2
Dutch Antilles/Caribbean: 2
Africa (other): 6
Middle East (other): 9
Ethnicity -
Caucasian 42 (53) 97 (97)
Black 25 (32) 0
Asian 7 (9) 0
Mixed 5 (6) 3 (3)
Primary cause of ESRD 0.787c
-Glomerulopathy 18 (23) 28 (28)
-Hemolytic uremic syndrome 4 (5) 6 (6)
-Urinary tract malformation 15 (19) 16 (16)
-Dysplasia 20 (26) 24 (24)
-Primary interstitial nephritis 1 (1) 4 (4)
-Tubular necrosis 5 (6) 8 (8)
Other 16 (20) 14 (14)
Educational attainment of the parents 0.007a
-Elementary school 15 (19) 12 (12)+1.36
-Secondary education 8 (10) 28 (28)+1.37
-Post-secondary education missing 9 (11) 30 (30)+1.38
-Missing 47 (60) 30 (30)+1.39
Initial treatment of ESRD. Age at
start of dialysis, years* median (range)
Total 6.4 (0–17.0) 6.4 (0–18.5) 0.551b
HD 10.0 (0–17.0) 8.3 (1.1–18.5) 0.814b
PD 2.1 (0–16.6) 4.9 (0–16.7) 0.078b
eGFR (ml/1.73 m2) at start
dialysis* 7.4 (3.5–20.5) 7.5 (2.4–31.5) 0.687b
“Poor condition” as reason to start dialysis 24 (30) 36 (36) 0.429a
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During the follow-up period, 88 children (33 non-
Western and 55 Western) received a kidney transplant. Prior
to transplantation, non-Western patients spent a significantly
longer time on dialysis than Western patients, with a median
of 30 months versus 15 months, respectively (p00.007)
(Fig. 1).
Dialysis outcomes
The incidence rate of peritonitis was 1.0 per patient year at
risk for non-Western and 0.41 per patient year at risk for
Western patients. The incidence rates of HD exit site/tunnel
infections were comparable in both groups (Table 3).
Table 2 Comparison of modes
of dialysis and medication use
between children with immi-
grant parents of non-western
European origin (non-Western)
and children with parents of
western-European origin
(Western)
Data are presented as n (per-
centage), * data are presented as
median (range), aChi-square test,
bMann–Whitney U test, 1From
start of dialysis until May 1,
2011 or until transplantation,
transition to adult care, or death.
2From start of dialysis until first
transplantation before May 1,
2011, HD hemodialysis, PD
peritoneal dialysis, Tx
transplantation
Dialysis characteristics Non-Western, n079 Western, n0100 p value
Duration and mode of dialysis
Total months on HD*1 16.8 (0.6–106.0) 6.5 (0.1-66.2) 0.003b
Total months on PD*1 11.4 (0.2–88.3) 13.6 (0.1–73.3) 0.756b
Duration of dialysis before first Tx*2 (months) n088 30.2 (5.0–99.0) 15.0 (0.0–66.7) 0.007b
Number of switches
HD to PD 10 7 0.712a
PD to HD 14 15 0.307a
Total hours on HD per week* 12 (3-24) 12 (3-24) 0.670b
Vascular access 0.080a
- Cimino fistula 23 (53%) 11 (33%)
- Central venous catheter 20 (47%) 22 (67%)
Medication prescription
Anti-hypertensive drugs 39 (52%) 61 (61%) 0.280a
> 2 anti-hypertensive drugs 14 (25%) 12 (29%) 0.603a
Erythropoietin 68 (91%) 92 (92%) 0.790a
Phosphate binder
-Calcium based 39 (52%) 44 (44%) 0.359a
-Non-calcium based 39 (52%) 51 (51%) 1.000a
Etalpha 60 (80%) 81 (81%) 1.000a
Growth hormone 25 (33%) 33 (33%) 1.000a
Prophylactic antibiotics exit site 17 (47%) 22 (35%) 0.242a
Table 1 (continued)
Non-Western, n079 (44) Western,
n0100 (56)
p value
First dialysis modality 0.046a
HD 41 (52) 37 (37)
PD 38 (48) 63 (63)
PD modality 0.241a
CCPD/APD 28 (78) 55 (82)
CAPD 7 (19) 7 (11)
Missing 1 (3) 5 (7)
Inclusion in RICH-Q
Prevalent patients 46 (58%) 63 (63%) 0.516a
Duration of dialysis before
inclusion months*1
HD (n042) 17.5 (3.8–63.4) 8.2 (3.1–65.3) 0.018b
PD (n046) 19.3 (4.1–77.5) 10.6 (3.4–49.4) 0.453b
Data are presented as n (percentage); *data are presented as median (range), a Chi-square test, bMann–WhitneyU test, c Fisher’s exact test, 1 From start of
dialysis until inclusion for the prevalent patients), eGFR estimated glomerular filtration rate Schwartz. (>Ref. 2009), HD hemodialysis, PD peritoneal
dialysis, CCPD continuous cycling peritoneal dialysis, CAPD continuous ambulatory peritoneal dialysis, APD automated peritoneal dialysis, RICH-Q
renal insufficiency therapy in children-quality assessment and improvement. Prevalent defined as >3 months treated with dialysis before inclusion
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The hospitalization rate in children older than 4 years was
lower in non-Western than in Western patients. Children
treated with PD were admitted to the hospital more often
than children on HD. Within the subgroups of HD and PD,
treatment modalities the hospitalization rates of non-
Western and Western patients did not differ significantly.
The number of days of hospitalization was not significantly
different between the groups either above or below the age
of 4 years.
Compared to Western patients, non-Western patients had
more peritonitis episodes, the mean difference [95% CI]
being 0.58 [0.03–1.14] episodes per year at risk, adjusted
for poor condition as the reason to start dialysis (Table 4a).
Signs of ROD at inclusion were present in 22 non-
Western (34%) and 15 Western patients (18%) (p00.028)
(Table 3). ROD was present before the start of dialysis in
27% and 11% of the non-Western and Western patients,
respectively. When adjusted for parental educational attain-
ment, the OR [95% CI] for ROD in non-Western patients
was 1.8 [0.6–5.5] (Table 5b).
Six children (3%) died during the follow-up period, three
non-Western and three Western patients. Four children (two
in each group) died of intercurrent diseases, one of Wilms’
tumor, one of congenital heart disease, and two due to
withdrawal of treatment because of multiple co-
morbidities. Two children (one in each group) died of
complications of the treatment of the underlying kidney
disease, one of pulmonary hypertension, and one due to a
complication of a central line.
Discussion
We found less favorable health outcomes and important
disparities in the management of children on dialysis treat-
ment with parents from non-Western European origin as
compared to those from Western origin in the Netherlands
and Belgium. We will discuss the possible reasons for these
disparities and formulate areas for further research.
In both countries, non-Western patients more often
received HD as the first mode of cRRT instead of PD as
compared to Western children. Although kidney transplan-
tation is considered to be the optimal mode of cRRT for
children with ESRD, in most circumstances dialysis treat-
ment as first cRRT is inevitable [9]. There is no consensus
on the optimal mode of dialysis treatment. Peritoneal dialy-
sis (PD) is offered to younger children, especially under the
age of 2 years or weighing less than 10 kg. Some centers
recommend PD instead of HD in children because of its
social advantages [10]. PD permits a relatively normal life-
style by allowing children to attend school full time with
less dietary and fluid restrictions compared to HD. In addi-
tion, obtaining vascular access for HD in children can be
challenging [11]. In some European countries, hemodialysis
(HD) is preferred for children over the age of 5 years [12].
Factors that are reported to influence the choice of therapy
include the age of the child (30%), parent preference (27%),
distance from the unit (14%), patient preference (11%),
social condition (7%), and inability to do one particular
mode (6%) [12, 13]. In our study, 40% of the centers
preferred HD for children>3 years old. We found that in
Western children, the preferred mode of dialysis according
to the center policy was less often followed than in non-
Western children. If the preferred mode of dialysis was not
followed in Western children, PD was chosen more often
than HD. In non-Western children, HD prevailed if the
preferred modality was not followed.
It is not clear whether the deviations from the center
policy had merely been the physicians’ or the patients’
choice. It is possible that Western parents more often prefer
a situation of having the child out of the hospital as much as
possible, as with PD, despite the burden of home therapy,
even in a situation where the physician advises differently.
Physicians, on the other hand, may have been reluctant to
offer a home dialysis program to some non-Western
patients. The preference for HD might even be due to a
more systematic physician bias in the treatment of non-
Western patients. Our findings are consistent with race-
associated disparities in the dialysis treatment of children
in the United States. Furth et al. found more use of HD
instead of PD in children of African American descent.
Family, patient, and provider preferences all accounted for
the difference in choice of therapy by race [14]. In addition,
they suggest that systematic racial bias specifically may
Fig. 1 Time from start of dialysis to first transplantation in non-
Western children compared to Western children, p00.007
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have contributed to the difference in dialysis modality
choice. The extent to which subtle or overt and systematic
provider preconceptions about race have affected dialysis
modality choice in the children in our study is unclear.
Table 3 Comparison of the outcomes between children with immigrant parents of non-western European origin (non-Western and children with
parents of western-European origin (Western) with end-stage renal disease
Non-Western Western P value IRR [95%CI]
Blood values (at inclusion) n Median (range) n Median (range)
Hemoglobin mmol/l
-Incident 30 6.8 (4.1–8.7) 34 6.5 (3.6–8.2) 0.174b
-Prevalent 46 6.9 (4.6–9.4) 60 7.0 (3.5–9.0) 0.871b
Phosphate mmol/l
-Incident 30 1.65 (1.02–3.16) 34 1.58 (0.82–2.96) 0.527b
-Prevalent 46 1.68 (0.78–2.58) 60 1.68 (0.85–2.79) 0.831b
Calcium mmol/l
-Incident 28 2.44 (1.25–3.24) 33 2.40 (1.89–2.76) 0.767b
-Prevalent 46 2.45 (2.00–3.09) 59 2.43 (1.90–3.58) 0.481b
iPTH pmol/l
-Incident 29 14.9 (0.1–159) 28 11.6 (0.1–121) 0.534b
-Prevalent 44 17.6 (0.3–158) 58 14.1 (0.4–176) 0.570b
Alkaline phosphatase U/l
-Incident 8 411 (71– 987) 10 233 ( 4–825) 0.324b
-Prevalent 22 408 (84–1,254) 24 201 (33–1,716) 0.043b
Homocysteine umol/l
-Incident 6 9.5 (4.2–14.2) 10 13.3 (5.3–30.7) 0.093b
-Prevalent 19 10.6 (3.0–26.0) 29 12.1 (6.0–113.0) 0.217b
Hypertension1
(at inclusion) 76 33 (43) 4 45 (47) 0.607
Renal osteodystrophy (at inclusion)
X-ray hand: Moderate or severe signs
Total 65 22 (34) 83 15 (18) 0.028a
-incident 22 6 (27) 29 3 (11) 0.150
-prevalent 43 16 (36) 54 12 (22) 0.120
Infection IRR [95%CI]
Number of peritonitis episodes per patient year PD at risk 34 1.00 60 0.41 - 2.44 [1.43–4.17]
Number of HD exit sites or tunnel infections per patient year
HD at risk
46 0.34 33 0.45 - 0.75 [0.38–1.50]
Hospitalization
Total number of hospitalizations per patient 79 100
Year at risk 2.72 3.71 - 0.73 [0.62–0.87]
Age<4 years 4.34 5.49 0.79 [0.60–1.03]
Age>4 years 2.29 3.12 0.73 [0.59–0.91]
HD 1.97 2.56 0.77 [0.58–1.03]
PD 3.34 3.33 1.00 [0.79–1.26]
Days of hospitalization per year 73 88
All ages 18 (0–282) 12 (0–196) 0.427b
<4 years 35 (7–282) 22 (0–196) 0.228b
>4 years 12 (0–162) 10 (0–158) 0.422b
Data are presented as n (percentage), * data are presented as median (range), a Chi-square test, bMann–Whitney U test; iPTH immunoreactive
parathyroid hormone, HD hemodialysis, PD peritoneal dialysis, IRR incidence rate ratio, 95% CI095% confidence interval. 1 Hypertension was
defined as systolic or diastolic blood pressures>p95 of the Task Force Report normal values corrected for age and gender [8]. Prevalent is defined
as >3 months treated with dialysis before inclusion. Incident is defined as included within 3 months after start of dialysis
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Table 4 Results of linear re-
gression analysis for episodes of
peritonitis/PD year at risk in 94
children treated with peritoneal
dialysis in all PD patients (5a)
and in all patients in whom also
data on the parental educational
attainment was obtained (5b)>
PD peritoneal dialysis
4a B 95% CI
Model with one determinant (n094)
Non-Western status 0.65 0.09–1.21
Multivariable models
1. Non-Western status 0.63 0.72–1.19
- Months on PD before inclusion –0.01 –0.09 – 0.08
2. Non-Western status 0.58 0.03–1.14
-“Poor condition” as reason to start –0.60 (–1.15) – (–0.05)
4b
Model with one determinant (n060)
Non-Western status 0.93 0.11–1.74
Multivariable models
1. Non-Western status 0.79 –0.04 – 1.62
-“Poor condition” as reason to start –0.55 –1.32 – 0.22
2. Non Western status 0.72 –0.13 – 1.56
-“Poor condition” as reason to start –0.52 –1.30 – 0.27
Parental educational attainment (reference category: “post secondary” )
-Elementary school 0.33 –0.59 – 1.25
-Secondary education –0.14 –0.96 – 0.67
Table 5 Results of logistic re-
gression analysis for renal
osteodystrophy in 148 children
treated with dialysis (5a) and in a
subgroup of 87 patients on dial-
ysis of whom we obtained data
on educational attainment of the
parents (5b)
ESRD end-stage renal disease
5. a OR 95% CI
Model with one determinant (n0148)
Non-Western status 2.32 1.09–4.96
Multivariable models
1. Non-Western status 2.25 1.05–4.82
Months on dialysis before diagnosed with ROD 1.00 1.00–1.00
2. Non-Western status 2.33 1.06–5.11
Cause of ESRD (reference category: “other”)
-Glomerulopathy 0.57 0.19–1.76
-Hemolytic uremic syndrome 0.27 0.03–2.57
-Urinary tract malformation 0.40 0.10–1.59
-Dysplasia 0.66 0.21–2.01
-Primary interstitial nephritis 1.12 0.83–14.92
-Tubular necrosis 1.55 0.33–7.36
3. Non-Western status 2.46 1.14–5.34
“Poor condition” as reason to start 2.13 0.97–4.63
5. b
Model with one determinant (n087)
Non-Western status 2.41 (0.85–6.80)
Multivariable model
1. Non-Western status 1.75 (0.56–5.47)
Educational attainment of parents (reference category: “post-secondary” )
-Elementary school 4.88 (1.20–19.77)
-Secondary education 2.33 (0.61–8.94)
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Financial motives may also play a role in the choice of
either HD or PD. In the United States, unequal access to
optimal medical care is an important cause for disparities in
care. For example, Young et al. describe that pediatricians are
facing the dilemma of rationing care to uninsured, undocu-
mented children, especially for expensive life-saving care
such as renal transplantation and dialysis [15]. However,
unlike in the United States, the social system in both the
Netherlands and Belgium provides few financial incentives
for choosing a certain treatment modality. Health insurance is
mandatory. All insured patients pay an income-dependent
contribution. In return, they receive all necessary medical
and paramedical care for free, including dietary, psychologi-
cal, and educational support. In the Netherlands, patients with
a chronic disease can apply for a personal budget for extra
help at home, depending on income and family situation. Even
immigrants or refugees who are staying in the Netherlands or
Belgium undocumented receive all necessary medical and
paramedical care, if necessary for free [16]. In 2010, the
Netherlands was ranked first in a study comparing the health
care systems of the US, Australia, Canada, Great Britain,
Germany, and New Zealand [17]. The study assessed five
measures of healthcare; quality, efficiency, access to care,
equity and, the ability to lead long, healthy, productive lives.
Non-Western patients spent significantly more time on
dialysis prior to transplantation. The transplantation process
involves a series of steps related to medical suitability, pre-
transplant work-up, the possibility of a family member to
donate, or movement up the waiting list for deceased donor
to eventual transplantation [18]. Some of these steps have
been examined individually in previous studies in the Unit-
ed States [19, 20]. The study of Ozminkowski et al. showed
that in the United States, blacks move up the waiting list at a
slower rate than whites [19]. Movement on the waiting list
has been studied extensively, and appears to reflect both
biological factors (e.g., HLA-based tissue typing) and non-
biological factors (e.g., transplant center characteristics
[20]). Furth et al. reported racial disparities regarding access
to the renal transplant waiting list in pediatric units in the
United States [21]. Whether these disparities were attribut-
able to differences in the timing of presentation to a nephrol-
ogist, physician bias in identification of transplant
candidates, or patient preferences was not clear.
The longer time on dialysis in our non-Western children
could partly be explained by a different mode of transplan-
tation. In an earlier study on the same cohort on transplan-
tation policy and outcomes in non-Western children with
end-stage renal disease, we found that non-Western patients
less often received donor kidneys from a living related
donor than deceased donor (DD) transplantations [22], con-
trary to Western patients.
Non-Western patients who were treated with PD more
often had peritonitis episodes than Western patients. This is
remarkable given the relatively small number of non-
Western patients on PD as compared to HD, which suggests
a positive selection for this modality. The incidence rates of
HD exit site/tunnel infections were similar in both groups,
but non-Western patients more often had a Cimino fistula.
This might be related to different policies followed in non-
Western and Western patients with respect to vascular ac-
cess. As discussed before, non-Western patients were less
often scheduled for living-related donor transplantation and
consequently more often prepared for deceased donor trans-
plantation with a longer expected time on HD. This may
have motivated physicians to choose for a Cimino fistula
more often in non-Western patients.
The hospitalization rate was lower in non-Western
patients>4 years than in Western patients of the same age.
This might be explained by the fact that relatively more non-
Western patients receive HD than Western patients. Children
on HD are monitored regularly and intravenous antibiotics
can be given during the HD treatment sessions, both circum-
stances that make admission less often necessary than in PD.
Consistent with this, both non-Western and Western patients
on PD were equally more often admitted than patients on
HD.
We found that ROD was more prevalent in non-Western
children. Nevertheless, in a multivariable analysis of a
smaller subgroup without missing values, the educational
attainment of the parents turned out to be a confounder of
this association. Renal osteodystrophy (ROD), which is
associated with a long duration of chronic kidney disease,
is a major clinical problem in young adults with pediatric
ESRD [23]. To detect ROD, a bone biopsy remains the 'gold
standard' investigation. Its invasive nature and the need for
specialized processing and interpretation limits the use of
bone biopsy in clinical practice [24]. Hand X-ray is not
invasive and has a high specificity (92%) for the detection
of ROD bone features [25].
ROD was already present before the start of dialysis in
six non-Western and three Western children. We have no
evidence that non-Western patients were less compliant with
therapy before they developed ESRD. We found no indica-
tion of non-adherence in surrogate outcome markers for
prevention of ROD such as iPTH, phosphate and medication
dosage of phosphate binders, and vitamin D derivates.
Therefore, genetic factors influencing for instance the vita-
min D status might have been involved. Prevention of ROD
requires extreme discipline to strictly follow the dietary and
medication regime. The combination of impaired schooling
of the parents and cultural misunderstandings may have
hampered compliance in some children of non-Western
background. These patients might profit from a culturally
tailored approach from the treatment team [26].
In the Netherlands, there has been a shift in the non-
Western population. Especially in children, we see a new
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generation from non-Western origin. They were born in the
Netherlands, and are mostly the second generation of non-
Western descent whose behavior differs from elderly first-
generation non-Western adults.
Perhaps this might be one of the explanations for the
difference between the results of the present study and those
of a recent Dutch study in adult immigrants that showed
increased survival for adult immigrant patients on dialysis in
the Netherlands compared to native Dutch dialysis patients
[27]. Another explanation might be that ESRD in adult
immigrant patients is due to different causes than in young
patients.
A limitation of this study is the exclusion of children who
had been transplanted before the start of the RICH-Q regis-
try. The inclusion of patients in the RICH-Q project started
in September of 2007. Only children that were treated with
dialysis were included in the present study. Children who
had been transplanted before this date were not included.
This probably has resulted in an overrepresentation of chil-
dren who are not suitable for (pre-emptive) transplantation,
which may have resulted in a relatively large proportion of
non-Western patients in this study. Therefore, the percentage
of non-Western patients in this study is higher than in the
general population. Another limitation is that we did not
collect information on language barriers, which have been
shown to impact a wide variety of health and healthcare
outcomes [28]. The parental educational attainment seemed
to be a confounder in the development of ROD. Unfortu-
nately, information on the educational attainment of the
parents was missing in the majority of non-Western Euro-
pean children.
In conclusion, children with end-stage renal disease with
parents of non-Western European origin more often receive
HD instead of PD as first cRRT modality, and stay on
dialysis longer before transplantation. These non-Western
patients have less favorable outcomes, such as an increased
risk for PD-associated peritonitis and renal osteodystrophy.
This situation might be improved by education of treatment
providers about these disparities and about the potential
roles of conscious and unconscious bias, cultural misunder-
standings, and language barriers.
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